-
UNDERSTANDING THE TECHNOLOGY> Recent Patents on MicroRNA-Induced Pluripotent Stem Cell Generation
-
Regulation of somatic cell reprogramming through inducible miRNA expression
-
MicroRNA Inhibits the Tumorigenecity of Human Pluripotent Stem Cells
-
MiRNA reprograms human skin cancer cells into a pluripotent ES-cell-like state
-
MicroRNA Inhibits the Tumorigenecity of Human Pluripotent Stem Cells
-
Chang-Lin S, Hung A, Chang DC, Lin YW, Ying SY and Lin SL (2016). “Novel glycylated sugar alcohols protect ESC-specific microRNAs from degradation in iPS cells.” Nucleic Acids Res 44(10): 4894-906.
-
Deng JH, Deng P, Lin SL and Ying SY (2015). “Gene silencing in vitro and in vivo using intronic microRNAs.” Methods Mol Biol 1218: 321-40.
-
Chen JS and Wu DT (2013). “Application of intronic microRNA agents in cosmetics.” Methods Mol Biol. 936: 325-41.
-
Chen JS and Lin SL (2013). “Recent patents on microRNA-induced pluripotent stem cell generation.” Recent Patents on Regenerative Medicine 3: 5-16.
-
Lin SL and Ying SY (2013). “Mechanism and method for generating tumor-free iPS cells using intronic microRNA miR-302 induction.” Methods Mol Biol 936: 295-312.
-
Kelley K and Lin SL (2012). “Induction of somatic cell reprogramming using the microRNA miR-302.” Prog Mol Biol Trasl Sci 111: 83-107.
-
Lin SL (2011). “Concise review: deciphering the mechanism behind induced pluripotent stem cell generation.” Stem Cells 11: 1645-9.
-
Lin SL, Chang DC, Lin CH, Ying SY, Leu D and Wu DT (2011). “Regulation of somatic cell reprogramming through inducible mir-302 expression.” Nucleic Acids Res 39(3): 1054-65.
-
Lin SL, Chang DC, Ying SY, Leu D and Wu DT (2010). “MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.” Cancer Res 22: 9473-82.
-
Chen JS, Leu D, Wu DT and Lin SL (2009). “MicroRNA-mediated skin lightening: an innovative cosmetic approach.” H&PC Today 2: 8-10.
-
Wu DTS, Chen JS, Chang DC and Lin SL (2008). “Mir-434-5p mediates skin whitening and lightening.” Clinical, Cosmetic and Investigational Dermatology 1: 19-35.
-
Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT and Ying SY (2008). “Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.” RNA 14(10):2115-24.
-
Lin SL and Chen J; Mechanism of miR‐302‐mediated iPS cell generation. Sell S (Ed.) Stem Cells Handbook. (in press). Springer Publishers press, New York, 2012.
-
Kelley K, Chang SJE, Lin SL; Mechanism of repeat‐associated microRNAs in fragile X syndrome. Neural Plasticity (in press), 2012.
-
Lin SL, Chen SKJ; Recent patents on microRNA‐induced pluripotent stem cell generation. Recent Patents on Regenerative Medicine (in press), 2012.
-
Lin SL; Deciphering the mechanism behind induced pluripotent stem cell generation. Stem Cells 29: 1645‐1649, 2011.
-
Lin SL, Chang D, Lin CH, Ying SY, Leu D and Wu DTS; Regulation of somatic cell reprogramming through inducible mir‐ 302 expression. Nucleic Acids Res. 39: 1054‐1065, 2011.
-
Lin SL, Chang D, Ying SY, Leu D and Wu DTS; MicroRNA miR‐302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of CDK2 and CDK4/6 cell cycle pathways. Cancer Res. 70: 9473‐9482, 2010.
-
Ying SY, Chang CP and Lin SL; Intron‐mediated RNA interference, intronic microRNAs, and applications. Methods Mol Biol. 629: 205‐237, 2010.
-
Ying SY and Lin SL; Intron‐mediated RNA interference and microRNA biogenesis. Methods Mol Biol. 487: 387‐413, 2009.
-
Chang SJE, Chang‐Lin S, Chang D, Ying SY and Lin SL; Repeat‐associated microRNA triggers fragile X syndrome in zebrafish. The Open Neuropsycho‐pharmacology J. 1: 6‐ 18, 2008.
-
Lin SL, ChangD, Chang‐Lin S, Lin CH, Wu DTS, Chen DT and Ying SY; Mir‐302 reprograms human skin cancer cells into a pluripotent ES‐cell‐like state. RNA 14: 2115‐2124, 2008.
-
Ying SY, Chang D and Lin SL; The microRNA (miRNA): Overview of the RNA gene that modulates gene functions. Mol Biotechnol. 38: 257‐268, 2008.
-
Lin SL, Kim H and Ying SY; Intron‐mediated RNA interference and microRNA (miRNA). Front. Biosci. 13: 2216‐2230, 2008.
-
Lin SL, Jiang A, Chang D, and Ying SY; Loss of mir‐146a function in hormone‐ refractory prostate cancer. RNA 14: 417‐ 424, 2008.
-
Lin SL, Chang D, Jiang A and Ying SY; Androgen receptor regulates CD168 expression and signaling in prostate cancer. Carcinogenesis 29: 282‐290, 2008.
-
Lin SL, Chang D and Ying SY; Hyaluronan stimulates transformation of androgen‐ independent prostate cancer. Carcinogenesis 28: 310‐320, 2007.